Login With Google
Itolizumab – new drug for covid-19
Why is it in news?
- The Drug Controller General of India recently approved Itolizumab as a novel biologic therapy for restricted emergency use.
Details:
- It is the drug used for psoriasis, a chronic skin disease.
- Psoriasis:
(1) It involves unregulated growth of some skin cells.
(2) It results into development of red patches mostly on knees and elbows, but also on some other parts of the body.
- The drug controls the hyper-activation of the immune system in response to SARS-CoV-2 virus.
- It prevents morbidity and mortality due to large generation of cytokine which damages lungs and other organs.